Skip to main content
OpenTrials
Completed

NCT Number: NCT07505706

Patient Journey in Palliative Care Within the NOVO Hospital Group.

This retrospective descriptive study aims to describe the sociodemographic, clinical, and organizational characteristics of patients identified as receiving palliative care who died in 2024 within the NOVO Hospital network.

Data from medical records will include patient characteristics, involvement of general practitioners, use of palliative care services, healthcare utilization, and conditions of death.

The study hypothesizes that improved characterization of these patients and their care trajectories will help identify opportunities for earlier palliative care referral and better coordination between hospital and community care.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Hospital Novo

Pontoise, 95300, France

About this study

Population aging and the increasing prevalence of chronic diseases and frailty have led to a growing demand for palliative care. End-of-life trajectories are frequently complex and involve multiple transitions between hospital care, home, and long-term care facilities. In many healthcare systems, a large proportion of healthcare expenditures in the last months of life is related to hospitalizations. A better understanding of the characteristics and care pathways of patients receiving palliative care is therefore essential to improve the organization and coordination of end-of-life care.

In France, general practitioners play a key role in the follow-up of patients and in coordinating care between hospital and community settings. However, the identification of palliative care needs and the timing of referral to specialized palliative care services remain heterogeneous. Improved knowledge of patient profiles and care trajectories may help identify opportunities to strengthen collaboration between hospital teams and primary care physicians.

This retrospective monocentric descriptive study will analyze patients identified as receiving palliative care who died in 2024 within the NOVO Hospital network. Data will be extracted from the medical record system and anonymized prior to analysis.

Collected variables will include sociodemographic characteristics, clinical information such as comorbidities, level of autonomy, and data related to the organization of care. Particular attention will be given to the involvement of general practitioners, the use of specialized palliative care teams, and access to home-based care services. The study will also examine healthcare utilization in the last months of life, including hospital admissions and emergency department visits, as well as end-of-life conditions such as the place of death, the presence of advance directives, and the use of continuous deep sedation.

By describing patient profiles and care trajectories, this study aims to identify potential factors associated with healthcare utilization and to highlight opportunities to improve early palliative care identification and coordination between hospital and community care.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patients who died between January 1, 2024, and December 31, 2024, in the hospital or in their personal living space (home, nursing home...)
  • Having "palliative care" status in their medical record
  • Receiving care at one of the six NOVO hospital sites (Pontoise, Magny-en-Vexin, Beaumont-sur-Oise, Marines, Saint-Martin-du-Tertre, Aincourt)
  • Whether or not they were followed by a mobile palliative care team

Exclusion criteria

None

Treatment and study plan

Primary outcomes

  1. Number and profiles of patients identified as receiving palliative care who died in 2024 within the NOVO Hospital network

    Time frame: Through study completion, an average of 3 months

    Description of the sociodemographic, clinical, and organizational characteristics of patients identified as receiving palliative care, including age, sex, living situation, level of autonomy, primary disease, comorbidities, presence of advance directives, and existence of a documented care plan.

Secondary outcomes

  1. Place of death and concordance with patient preferences

    Time frame: Through study completion, an average of 3 months

    Assessment of the actual place of death (hospital, home, nursing home or other setting) and comparison with the place of death expressed in advance directives or documented care plans when available

  2. Involvement of general practitioners in palliative care management

    Time frame: Through study completion, an average of 3 months

    Evaluation of the presence of a primary care physician and their involvement in the patient's palliative care pathway, including participation in care planning and coordination with hospital teams

  3. Healthcare utilization in the last months of life

    Time frame: At the end of the study, an average of 3 months

    Number of hospital admissions and emergency department visits during the last six months of life

  4. Timing of referral to palliative care

    Time frame: Through study completion, an average of 3 months

    Time interval between the identification of a palliative situation and the first contact with palliative care services.

  5. Explore ways to improve the early identification of palliative care needs and ensure continuity of care between home and hospital

    Time frame: Through study completion, an average of 3 months

    Time between the date of death and the start of palliative care

Sponsors and collaborators

Lead sponsor

Hôpital NOVO

Other

Registry information

Official study title

A Descriptive and Analytical Study of Patients Who Died in 2024 While Receiving Palliative Care at NOVO Hospital: Patient Characteristics and Implications for General Practice?

Acronym: NOVOPAL

Important dates

Study start
2026
Primary completion
2026
Study completion
2026
First posted
Apr 1, 2026
Registry last updated
Jul 10, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.